Superior effect of Heparin and dual antiplatelet therapy on infarct related artery in acute MI patients on FMC prior to PCI
Main Authors: | D. Kahali, R. Mondal |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-12-01
|
Series: | Indian Heart Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0019483215005866 |
Similar Items
-
Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
by: Solheim Svein, et al.
Published: (2013-01-01) -
Dual antiplatelet therapy (DAPT) in post-PCI patients beyond one year
by: A.K. Singh, et al.
Published: (2017-11-01) -
Clinical efficacy and safety of tirofiban combined with conventional dual antiplatelet therapy in ACS patients undergoing PCI
by: Yong-zhe Guo, et al.
Published: (2021-08-01) -
Triple versus dual antiplatelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI) – Our hospital experience
by: Karandeep Singh, et al.
Published: (2015-12-01) -
Are We Optimizing the Use of Dual Antiplatelet Therapy in Patients Hospitalized with Acute Myocardial Infarction?
by: Hariri, Essa H.
Published: (2019)